Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk.
- 1 December 1989
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 80 (6), 1501-1513
- https://doi.org/10.1161/01.cir.80.6.1501
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Left Ventricular Thrombi and Cerebral EmbolismNew England Journal of Medicine, 1989
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- The Natural History of Lone Atrial FibrillationNew England Journal of Medicine, 1987
- Coronary Angioscopy in Patients with Unstable Angina PectorisNew England Journal of Medicine, 1986
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Failure of Antiplatelet and Anticoagulant Therapy to Improve Patency of Grafts after Coronary-Artery BypassNew England Journal of Medicine, 1979
- Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial InfarctionNew England Journal of Medicine, 1977